Geisinger launches new study to learn more about sleep and sleep disorders
,
Researchers in Danville, Bloomsburg, Lewistown and Wilkes-Barre open enrollment for national clinical trial
DANVILLE, Pa. – Geisinger has launched its participation in a new research program led by the Stanford University School of Medicine. The study, titled Stanford Technology, Analytics, and Genomics in Sleep (STAGES), is designed to provide investigators with more information about sleep and sleep disorders. Geisinger is currently accepting participants and will enroll over 11,000 individuals.
Geisinger is conducting the research in conjunction with a cohort of other medical and sleep research facilities including Stanford School of Medicine, Mayo Clinic, St. Luke’s Hospital, MedSleep, and Bogan Sleep Consultants. The study will enroll 30,000 participants in total.
“There is so much about sleep and sleep disorders that we do not fully understand,” said Anne Marie Morse, DO, principal investigator of the study and sleep specialist at Geisinger. “Sleep impacts everything from physical and mental health to a person’s work ability and even the health of their personal relationships. This research will help doctors learn more and find better solutions to treat sleep disorders.”
Participants must be 13 years old or older and be referred to a Geisinger Sleep Clinic. Participation includes completing questionnaires and other research activities. Participants will be seen at sleep clinics in Danville at Geisinger Medical Center, in Bloomsburg at Geisinger Bloomsburg Hospital, in Wilkes-Barre at the Geisinger South Wilkes-Barre Sleep Clinic and in Lewistown at Geisinger Lewistown Hospital. Recruitment may expand to other Geisinger locations.
For additional information or to sign up as a participant of the STAGES study, visit geisinger.org/STAGES or call 570-214-1651.
Geisinger is conducting the research in conjunction with a cohort of other medical and sleep research facilities including Stanford School of Medicine, Mayo Clinic, St. Luke’s Hospital, MedSleep, and Bogan Sleep Consultants. The study will enroll 30,000 participants in total.
“There is so much about sleep and sleep disorders that we do not fully understand,” said Anne Marie Morse, DO, principal investigator of the study and sleep specialist at Geisinger. “Sleep impacts everything from physical and mental health to a person’s work ability and even the health of their personal relationships. This research will help doctors learn more and find better solutions to treat sleep disorders.”
Participants must be 13 years old or older and be referred to a Geisinger Sleep Clinic. Participation includes completing questionnaires and other research activities. Participants will be seen at sleep clinics in Danville at Geisinger Medical Center, in Bloomsburg at Geisinger Bloomsburg Hospital, in Wilkes-Barre at the Geisinger South Wilkes-Barre Sleep Clinic and in Lewistown at Geisinger Lewistown Hospital. Recruitment may expand to other Geisinger locations.
For additional information or to sign up as a participant of the STAGES study, visit geisinger.org/STAGES or call 570-214-1651.
About Geisinger
Geisinger is committed to making better health easier for the more than 1 million people it serves. Founded more than 100 years ago by Abigail Geisinger, the system now includes 10 hospital campuses, a health plan with more than half a million members, a research institute and the Geisinger College of Health Sciences, which includes schools of medicine, nursing and graduate education. With more than 25,000 employees and 1,700+ employed physicians, Geisinger boosts its hometown economies in Pennsylvania by billions of dollars annually. Learn more at geisinger.org or connect with us on Facebook, Instagram, LinkedIn and Twitter.
For media inquiries, contact our team.